E-LIB Suche - Ergebnisse für: Meletios A. Dimopoulos - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Progression-free survival as a surrogate endpoint for overa..:

Dimopoulos, Meletios ; Sonneveld, Pieter ; Manier, Salomon...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Belantamab mafodotin, lenalidomide, and dexamethasone in tr..:

Gavriatopoulou, Maria ; Ntanasis‐Stathopoulos, Ioannis ; Malandrakis, Panagiotis...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

3

ciRS‐7 circular RNA overexpression in plasma cells is a pro..:

Papatsirou, Maria ; Kontos, Christos K. ; Ntanasis‐Stathopoulos, Ioannis...
eJHaem. , 2024

Link: https://doi.org/10.1002/..

4

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide..:

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 165-176.e4 , 2024

Link: https://doi.org/10.1016/..

5

Impact of prior treatment on selinexor, bortezomib, dexamet..:

Mateos, Maria‐Victoria ; Engelhardt, Monika ; Leleu, Xavier...
European Journal of Haematology. 113 (2024) 2 - p. 242-252 , 2024

Link: https://doi.org/10.1111/..

6

Ixazomib plus daratumumab and dexamethasone: Final analysis..:

Delimpasi, Sosana ; Dimopoulos, Meletios A. ; Straub, Jan...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

7

Single‐cell analysis of MYD88L265P and MYD88WT Waldenström ..:

Bagratuni, Tina ; Aktypi, Foteini ; Theologi, Ourania...
HemaSphere. 8 (2024) 2 - p. , 2024

Link: https://doi.org/10.1002/..

8

Daratumumab for patients with myeloma with early or late re..:

Spencer, Andrew ; Moreau, Philippe ; Mateos, Maria-Victoria...
Blood Advances. 8 (2024) 2 - p. 388-398 , 2024

Link: https://doi.org/10.1182/..

9

Efficacy and safety of daratumumab with ixazomib and dexame..:

Terpos, Evangelos ; Ntanasis‐Stathopoulos, Ioannis ; Gavriatopoulou, Maria...
American Journal of Hematology. 99 (2024) 3 - p. 396-407 , 2024

Link: https://doi.org/10.1002/..

10

The Interplay between the DNA Damage Response (DDR) Network..:

Malamos, Panagiotis ; Papanikolaou, Christina ; Gavriatopoulou, Maria...
International Journal of Molecular Sciences. 25 (2024) 13 - p. 6991 , 2024

Link: https://doi.org/10.3390/..

11

Prognosis of COVID-19 severity using DERGA, a novel machine..:

Asteris, Panagiotis G. ; Gandomi, Amir H. ; Armaghani, Danial J....
European Journal of Internal Medicine. 125 (2024) - p. 67-73 , 2024

Link: https://doi.org/10.1016/..

12

Belantamab mafodotin: an important treatment option for vul..:

Mateos, Maria Victoria ; Weisel, Katja ; Terpos, Evangelos...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

13

Thrombotic and bleeding complications in patients with AL a..:

Fotiou, Despina ; Theodorakakou, Foteini ; Spiliopoulou, Sotiria...
British Journal of Haematology. 204 (2024) 5 - p. 1816-1824 , 2024

Link: https://doi.org/10.1111/..

14

Exploring the molecular biomarker utility of circCCT3 in mu..:

Papatsirou, Maria ; Kontos, Christos K. ; Ntanasis‐Stathopoulos, Ioannis...
HemaSphere. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

15

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenal..:

Weisel, Katja ; Dimopoulos, Meletios A. ; Beksac, Meral...
Leukemia & Lymphoma. 65 (2024) 4 - p. 481-492 , 2024

Link: https://doi.org/10.1080/..

1-15